Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFSF2/TNFa Antibody (Infliximab)

Catalog No.
F1050
Anti-TNFSF2/TNFa Antibody (Infliximab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α. Infliximab blocks the interaction of TNF-α with TNF-α receptor 1 (TNFR1) and TNFR2. Infliximab is used in the study of autoimmunity, chronic inflammatory diseases, and diabetic neuropathy.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.98 kDa

Shipping

Dry ice

Cas No.

170277-31-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

TA-650, Remicade

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P01375

Reactivity

Human, Gorilla

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Immobilized human TNFa, Fc Tag at 2 ug/mL can bind Anti-TNFSF2/TNFa Antibody (Infliximab)

Target

TNFSF2 / TNFa

Note

Please avoid freeze-thaw cycles.